Ventas Stock Hits New 52-Week High (VTR)

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

NEW YORK ( TheStreet) -- Ventas (NYSE: VTR) hit a new 52-week high Wednesday as it is currently trading at $83.34, above its previous 52-week high of $83.22 with 437,768 shares traded as of 11:35 a.m. ET. Average volume has been 1.4 million shares over the past 30 days.

Ventas has a market cap of $24.13 billion and is part of the financial sector and real estate industry. Shares are up 28.1% year to date as of the close of trading on Tuesday.

Ventas, Inc. is a publicly owned real estate investment trust. The firm engages in investment, management, financing, and leasing of properties in the healthcare industry. It invests in the real estate markets of the United States and Canada. The company has a P/E ratio of 64.3, above the S&P 500 P/E ratio of 17.7.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

TheStreet Ratings rates Ventas as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, increase in net income, growth in earnings per share and notable return on equity. We feel these strengths outweigh the fact that the company shows low profit margins. You can view the full Ventas Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

Exclusive Offer: Jim Cramer's 'go-to' small/mid-cap guru Bryan Ashenberg only buys stocks he thinks could return 50-100% See his top picks for 14-days FREE.
null

If you liked this article you might like

Ventas Medical REIT: Cramer's Top Takeaways

When it Drops, it's Time to Shop: Cramer's 'Mad Money' Recap (Tuesday 9/12/17)

Kindred Sells Skilled Nursing Facility Business for $700M

Don't Forget Why You Love Tech Stocks Like Amazon, Jim Cramer Explains

High-Dividend Ventas: A Dual Play on Real Estate and Health Care